coronavirus

Moscow:  A team of Russian researchers has uncovered the mechanisms behind the emergence of new and dangerous coronavirus variants, such as Alpha, Delta, Omicron, and others. The team, led by those from the National Research University…
Read More...

New York: For at least six months after Covid-19 vaccination, antibodies produced by immune cells become steadily more formidable and more precisely targeted against the virus that causes Covid-19, according to a study of the antibody…
Read More...

The Wuhan scientists have warned of a potential threat of high fatality due to a newly discovered coronavirus NeoCoV . The NeoCoV virus discovered in South Africa is reportedly related to the Middle East respiratory syndrome MERS-COV.…
Read More...

New-Delhi: The Drugs Controller General of India (DCGI) on Thursday granted conditional market approval for Covishield and Covaxin. However, it is important to note that the market approval does not mean that the vaccines will be…
Read More...

Washington: Amid an ongoing resurgence across the world, the global coronavirus caseload has topped 345.8 million, while the deaths have surged to more than 5.58 million and vaccinations to over 9.76 billion, according to Johns Hopkins…
Read More...

Bhubaneswar: Odisha has reported over 10,000 covid-19 positive cases for the third consecutive day. The state on Saturday reported a massive spike in Covid cases with 10, 856 positive cases including 3087 cases from Khordha have been…
Read More...

London: People with higher levels of T-cells from common cold coronaviruses are less likely to become infected with SARS-CoV-2, according to a new research. The study, by Imperial College London researchers, provides the first evidence of…
Read More...

Bhubaneswar: Amid sharp rise in Covid cases in the country, the central government has advised the states and union territories (UTs) to buffer stock of medical oxygen sufficient for at least 48 hrs at health facilities providing in-patient…
Read More...

New York:  Pfizer's vaccine that specifically targets the Omicron variant of Covid-19 will be ready in March, the pharmaceutical giant's CEO Albert Bourla has said. Bourla said Omicron is a more difficult target than the previous…
Read More...